| Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational … M O'Dwyer, J Peklar, P McCallion, M McCarron, MC Henman BMJ open 6 (4), e010505, 2016 | 238 | 2016 |
| Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research M O’Dwyer, P McCallion, M McCarron, M Henman Therapeutic advances in drug safety 9 (9), 535-557, 2018 | 83 | 2018 |
| Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland M O'dwyer, J Peklar, N Mulryan, P McCallion, M McCarron, MC Henman Journal of Intellectual Disability Research 61 (10), 969-983, 2017 | 68 | 2017 |
| Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross‐sectional study J O'Connell, É Burke, N Mulryan, C O'Dwyer, C Donegan, P McCallion, ... British journal of clinical pharmacology 84 (3), 553-567, 2018 | 61 | 2018 |
| Health, wellbeing and social inclusion: Ageing with an intellectual disability in Ireland M McCarron, M Haigh, P McCallion, P McCallion, R Carroll, E Burke, ... Evidence from the first ten years of The Intellectual Disability Supplement …, 2017 | 57 | 2017 |
| Association of anticholinergic burden with adverse effects in older people with intellectual disabilities: an observational cross-sectional study M O'Dwyer, ID Maidment, K Bennett, J Peklar, N Mulryan, P McCallion, ... The British Journal of Psychiatry 209 (6), 504-510, 2016 | 57 | 2016 |
| Pharmacists’ medicines-related interventions for people with intellectual disabilities: a narrative review M O’Dwyer, A Meštrović, M Henman International Journal of Clinical Pharmacy 37, 566-578, 2015 | 48 | 2015 |
| Medication and supplement use in older people with and without intellectual disability: an observational, cross-sectional study J Peklar, M Kos, M O’Dwyer, M McCarron, P McCallion, RA Kenny, ... PLoS One 12 (9), e0184390, 2017 | 45 | 2017 |
| The association of life events and mental ill health in older adults with intellectual disability: results of the wave 3 intellectual disability supplement to the Irish … L Bond, R Carroll, N Mulryan, M O'Dwyer, J O'Connell, R Monaghan, ... Journal of Intellectual Disability Research 63 (5), 454-465, 2019 | 36 | 2019 |
| Prevalence and associated factors of problem behaviours among older adults with intellectual disabilities in Ireland C O’Dwyer, P McCallion, É Burke, R Carroll, M O’Dwyer, M McCarron Research in developmental disabilities 80, 192-204, 2018 | 34 | 2018 |
| Quality improvement in the management of people with epilepsy and intellectual disability: the development of clinical guidance L Watkins, M O’Dwyer, M Kerr, M Scheepers, K Courtenay, R Shankar Expert opinion on pharmacotherapy 21 (2), 173-181, 2020 | 33 | 2020 |
| Prevalence and patterns of antipsychotic use and their associations with mental health and problem behaviours among older adults with intellectual disabilities C O'Dwyer, P McCallion, M Henman, M McCarron, E O'Leary, E Burke, ... Journal of Applied Research in Intellectual Disabilities 32 (4), 981-993, 2019 | 33 | 2019 |
| Quantitative examination of the bone health status of older adults with intellectual and developmental disability in Ireland: a cross-sectional nationwide study É Burke, R Carroll, M O’Dwyer, JB Walsh, P McCallion, M McCarron BMJ open 9 (4), e026939, 2019 | 31 | 2019 |
| Biopsychosocial factors associated with depression and anxiety in older adults with intellectual disability: results of the wave 3 Intellectual Disability Supplement to The … L Bond, R Carroll, N Mulryan, M O'dwyer, J O'Connell, R Monaghan, ... Journal of intellectual disability research 64 (5), 368-380, 2020 | 26 | 2020 |
| Prevalence and patterns of anti‐epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities M O'dwyer, J Peklar, N Mulryan, P McCallion, M McCarron, MC Henman Journal of Intellectual Disability Research 62 (3), 245-261, 2018 | 24 | 2018 |
| New anti-seizure medication for elderly epileptic patients L Watkins, M O’Dwyer, R Shankar Expert Opinion on Pharmacotherapy 20 (13), 1601-1608, 2019 | 23 | 2019 |
| Medication burden and frailty in older adults with intellectual disability: an observational cross‐sectional study J O'Connell, MC Henman, N McMahon, É Burke, P McCallion, ... Pharmacoepidemiology and drug safety 29 (4), 482-492, 2020 | 22 | 2020 |
| Design and implementation of an integrated competency-focused pharmacy programme: a case report TJ Ryan, T Grimes, MC Henman, EN Sheachnasaigh, M O’Dwyer, ... Pharmacy 7 (3), 121, 2019 | 22 | 2019 |
| Laxative use among older adults with intellectual disability: a cross-sectional observational study H AlMutairi, M O’Dwyer, E Burke, M McCarron, P McCallion, MC Henman International Journal of Clinical Pharmacy 42, 89-99, 2020 | 20 | 2020 |
| Bone health, intellectual disability and epilepsy: An observational community‐based study R Winterhalder, J McCabe, C Young, K Lamb, I Sawhney, C Jory, ... Acta Neurologica Scandinavica 145 (6), 753-761, 2022 | 19 | 2022 |
